Such a research agenda, if fruitful, will eventually give rise to a shining exhibition of human ingenuity—after thousands of years unknowingly using a CB1R agonist from nature as medicine, humanity has a chance to develop its own synthetic “polar opposite” and save itself from the unrelenting metabolic disease rampage. Here, CNR1 is linked to metabolic disease.